Performance Comparison of a Flow Cytometry-based and Two Commercial Chemiluminescent Immunoassays for Detection and Quantification of Antibodies Binding to SARS-CoV-2 Spike Protein
Arantxa Valdivia, Fabián Tarín, María Jesús Alcaraz, Paula Piñero, Ignacio Torres, Francisco Marco, Eliseo Albert, David Navarro
doi: https://doi.org/10.1101/2021.04.06.21254995
Arantxa Valdivia
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Fabián Tarín
2Hematology Department, Hospital General Universitario Alicante, Spain
María Jesús Alcaraz
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Paula Piñero
2Hematology Department, Hospital General Universitario Alicante, Spain
Ignacio Torres
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Francisco Marco
3Immunology Department, Hospital General Universitario Alicante, Spain
Eliseo Albert
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
David Navarro
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
4Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
Data Availability
The data that support the findings of this study are available on request from the corresponding author.
Posted April 09, 2021.
Performance Comparison of a Flow Cytometry-based and Two Commercial Chemiluminescent Immunoassays for Detection and Quantification of Antibodies Binding to SARS-CoV-2 Spike Protein
Arantxa Valdivia, Fabián Tarín, María Jesús Alcaraz, Paula Piñero, Ignacio Torres, Francisco Marco, Eliseo Albert, David Navarro
medRxiv 2021.04.06.21254995; doi: https://doi.org/10.1101/2021.04.06.21254995
Performance Comparison of a Flow Cytometry-based and Two Commercial Chemiluminescent Immunoassays for Detection and Quantification of Antibodies Binding to SARS-CoV-2 Spike Protein
Arantxa Valdivia, Fabián Tarín, María Jesús Alcaraz, Paula Piñero, Ignacio Torres, Francisco Marco, Eliseo Albert, David Navarro
medRxiv 2021.04.06.21254995; doi: https://doi.org/10.1101/2021.04.06.21254995
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2960)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4383)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)